The "Genetic Testing Market by Type, Technology, Application: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com’s offering. The genetic ...

Neurofibromatosis type 2 is most often diagnosed based on the presence of physical symptoms that are part of the specific diagnostic criteria for the disorder. Genetic testing for the NF2 mutation is ...

In the United States, approximately 1.9 million new cases of cancer were expected in 2023, and more than 18 million Americans have a history of invasive cancer. 1 When an oncologist is looking across ...

Genetic testing can be a fearful, daunting, overwhelming, exciting, or joyful experience. In many cases, the emotions of people who pursue genetic testing can be described with more than just one of ...

Genetic testing for schwannomatosis is available and may be appropriate for some people. The current test identifies a mutation in the SMARCB1 gene, which predisposes an individual to developing the ...

Add Yahoo as a preferred source to see more of our stories on Google. Vince Fleming/Unsplash Finding an effective antidepressant can be as hit-or-miss as finding a drinkable cappuccino in a strip mall ...

Noninvasive prenatal screening, involving analysis of fetal cell-free DNA in maternal blood, is currently available only for a small number of conditions caused by large chromosomal abnormalities.

Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare disease. Of the 7,000 known RD conditions, 80% have a genetic origin, yet over ...

Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, ...